La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Dermapharm Holding Gestion
Gestion contrôle des critères 4/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Hans-Georg Feldmeier
Directeur général
€1.4m
Rémunération totale
| Pourcentage du salaire du PDG | 59.7% |
| Durée du mandat du directeur général | 7.1yrs |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.1yrs |
Mises à jour récentes de la gestion
Recent updates
Here's Why Dermapharm Holding (ETR:DMP) Has A Meaningful Debt Burden
Sep 28
Dermapharm Holding SE Beat Revenue Forecasts By 6.7%: Here's What Analysts Are Forecasting Next
Aug 31Dermapharm Holding SE's (ETR:DMP) P/E Still Appears To Be Reasonable
Aug 17It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope
Jun 21These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €83m |
| Mar 31 2024 | n/a | n/a | €57m |
| Dec 31 2023 | €1m | €821k | €62m |
| Sep 30 2023 | n/a | n/a | €95m |
| Jun 30 2023 | n/a | n/a | €123m |
| Mar 31 2023 | n/a | n/a | €146m |
| Dec 31 2022 | €1m | €800k | €134m |
| Sep 30 2022 | n/a | n/a | €176m |
| Jun 30 2022 | n/a | n/a | €185m |
| Mar 31 2022 | n/a | n/a | €211m |
| Dec 31 2021 | €1m | €800k | €210m |
| Sep 30 2021 | n/a | n/a | €162m |
| Jun 30 2021 | n/a | n/a | €123m |
| Mar 31 2021 | n/a | n/a | €95m |
| Dec 31 2020 | €736k | €411k | €86m |
Rémunération vs marché: La rémunération totale de Hans-Georg ($USD 1.52M ) est dans la moyenne des entreprises de taille similaire sur le marché German ($USD 1.61M ).
Rémunération et revenus: La rémunération de Hans-Georg a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Hans-Georg Feldmeier
7.1yrs
Titularisation
€1,375,000
Compensation
Dr. Hans-Georg Feldmeier is the Chief Executive Officer and Chairman of the Management Board at Dermapharm Holding SE and also serves as Member of the Management Board from August 2017.
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Chairman of the Management Board | 7.1yrs | €1.38m | pas de données | |
| CFO, Chief Compliance Officer & Member of Management Board | 1.8yrs | €617.00k | pas de données | |
| Chief Marketing Officer & Member of Management Board | 2yrs | €612.00k | pas de données | |
| Head of Investor Relations & Corporate Communications | no data | pas de données | pas de données |
2.0yrs
Durée moyenne de l'emploi
Gestion expérimentée: L'équipe de direction de DMP est considérée comme expérimentée (ancienneté moyenne 2 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Independent Member of Supervisory Board | 6.7yrs | €80.00k | pas de données | |
| Chairman of the Supervisory Board | 7.1yrs | €80.00k | pas de données | |
| Independent Vice Chairman of the Supervisory Board | 7.1yrs | €80.00k | pas de données |
7.1yrs
Durée moyenne de l'emploi
68yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de DMP sont considérés comme expérimentés (ancienneté moyenne 7 ans).